Dicyclomine vs. Anafortan (Camylofin) for Abdominal Pain in Pregnancy

TL;DR

Dicyclomine

• Historical data exists from its use in the Bendectin formulation (used by ~30% of American pregnant women for nausea/vomiting of pregnancy in the 1970s–80s), which provided substantial human safety data.
• Classified as relatively acceptable for use in pregnancy when indicated.
• ⚠️ Contraindicated in breastfeeding — associated with infant apnea risk.
• One important caveat: Yamada's Gastroenterology also notes antispasmodics as a class "should be avoided in pregnancy as their safety has not been fully established" — reflecting that use should still be justified clinically.

— Yamada's Textbook of Gastroenterology, 7th ed., Table 40.6: Pharmacological treatment of abdominal pain in pregnancy

Anafortan (Camylofin Dihydrochloride)

• Used in obstetric practice primarily for cervical ripening and labor augmentation (shortening active labor duration) — not as a routine analgesic for abdominal pain during pregnancy.
• Evidence for its use in obstetrics is largely from Indian literature in the context of labor, not for pain relief during early/mid pregnancy.
• No large, controlled human teratogenicity/safety data comparable to dicyclomine.
• It is not absent from pregnancy contexts — but its role is labor management, not analgesia.

Head-to-Head Summary

Practical Guidance

• For spasmodic abdominal pain in pregnancy (e.g., IBS, uterine round ligament pain, GI spasm): Dicyclomine is the better-supported choice when an antispasmodic is deemed necessary.
• Non-pharmacological options (heat, rest, positioning) and acetaminophen/paracetamol (for pain) should always be tried first.
• NSAIDs (including diclofenac) are contraindicated after 20 weeks gestation.
• Hyoscine/buscopan is another option but also has limited human data ("caution advised").
• Always assess the underlying cause of abdominal pain in pregnancy before treating symptomatically — surgical causes (appendicitis, ectopic, placental abruption) must be ruled out.

Sources: Yamada's Textbook of Gastroenterology, 7th ed.; Goodman & Gilman's Pharmacological Basis of Therapeutics; Camylofin in Obstetrics – IJRCOG; Practo: Anafortan Injection

⚠️ Important Clarification: "Dichorionic Monoamniotic" Twins — Does This Exist?

Twin Classification: Chorionicity and Amnionicity

— Creasy & Resnik's Maternal-Fetal Medicine, 9th ed., Chapter on Zygosity and Chorionicity

"Dichorionic monoamniotic" = does not occur naturally and is not a recognised twin type.

The Four Valid Twin Placentation Types

Monochorionic Monoamniotic (MCMA) Twins — Full Overview

Definition

Pathogenesis

Placental Features

• Cord insertions are typically very close together on the chorionic plate
• Universal artery-to-artery (AA) and vein-to-vein (VV) anastomoses — large caliber, superficial
• Cords are almost always entangled (complex patterns)
• Cord abnormalities: single umbilical artery, furcate insertion, abnormal peripheral insertion

Prenatal Diagnosis

• No dividing membrane visualised on ultrasound by an experienced sonographer
• Cord entanglement confirmed by colour Doppler — detectable as early as 10 weeks' gestation (pathognomonic)
• Single yolk sac before 10 weeks (less specific; requires follow-up)

Monoamniotic twin placenta: closely inserted, entangled umbilical cords (Creasy & Resnik)

Complications

Antenatal Management

• Intensive fetal surveillance from viability (~24 weeks), because cord accidents are unpredictable
• Daily NSTs from 24–26 weeks to monitor variable decelerations
• If variable decelerations increase → continuous CTG monitoring
• Inpatient vs. outpatient: The MONOMONO study (multicenter, retrospective) found a trend toward lower fetal demise with inpatient management (3.3% vs. 10.8%), but this was not significant on cluster analysis — evidence remains inconclusive
• Sulindac (prostaglandin inhibitor to reduce AFV and stabilise fetal lie) has been proposed theoretically but has no proven safety or efficacy

Delivery

• Timing: Elective caesarean section at 32–34 weeks after antenatal corticosteroids — recommended by ACOG
• Continuing beyond 34 weeks is difficult to justify given ongoing stillbirth risk and high neonatal survival at this gestational age
• Mode: Caesarean delivery is the standard once viability is reached; vaginal delivery is possible but high CS conversion rate
• Cord precautions: Case reports of cutting the nuchal cord of the second twin after first twin's head delivery

— Creasy & Resnik's Maternal-Fetal Medicine, 9th ed., Chapter 37: Monoamniotic Twins

Summary Points for Exam/Clinical Use

1. "Dichorionic monoamniotic" — does not exist (common distractor in MCQs)
2. Monoamniotic twins are always monochorionic (MCMA)
3. Division occurs day 8–12 after fertilization
4. Diagnostic hallmark on ultrasound: cord entanglement on colour Doppler
5. Biggest risk: cord accidents (not TTTS — though TTTS can occur)
6. Deliver at 32–34 weeks by caesarean section
7. MCMA mortality was historically >50%; modern intensive surveillance has reduced this to ~2–6%